Delaware, March 07, 2017 -- The report “Electrophysiology Market by Product (EP Ablation Catheters, EP Laboratory Devices, EP Diagnostic Catheters, Access Devices), Indication (Atrial Fibrillation, Atrial Flutter, Atrioventricular Nodal Reentry Tachycardia, Wolff-Parkinson-White Syndrome) - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022”, available on MarketIntelReports, estimates that the market will register a CAGR of 13.4% till 2022.
Browse numerous Market Tables as well as Figures which are spread through 120 Pages and an in-depth TOC on the “Electrophysiology Market 2014-2022”
Scope & Regional Forecast of the Electrophysiology Market
Electrophysiology (EP) is the branch of science that deals with the study of electric activity in the human body. EP devices are used to treat abnormal electrical properties of cell and tissues that leads to various cardiac arrhythmias. Innovative EP technologies are developed to improve the diagnosis and treatment of life-threatening conditions, such as atrial fibrillation (AF), atrial flutter, Wolff-Parkinson-White Syndrome (WPW), atrioventricular nodal reentry tachycardia (AVNRT), and other cardiac arrhythmias.
Request Sample PDF Brochure @ http://www.marketintelreports.com/pdfdownload.php?id=li%2016452
The growing incidence of AF-one of the most common heart rhythm disorder or arrhythmia is the prime factor to drive the growth of the EP market. In addition, cardiovascular diseases treatment market is assured to grow on account of unmet clinical needs and upcoming treatment modifications. Increase in baby boomer generation with high-risk of targeted diseases and increase in adoption of EP catheter ablation propels the market growth. Moreover, rise in focus of the key players toward innovative EP technologies (such as 3D mapping systems, novel diagnostic catheters, and laser ablation systems), has fuel the demand for EP devices across various settings in EP labs. However, stringent government regulations, high cost of the advanced EP devices, preference to pharmaceutical interventions (drugs) over EP treatment devices and dearth of skilled & experienced electrophysiologists are set to restrain the market growth. The world electrophysiology market is projected reach $8,271 Million by 2022, growing at a CAGR of 13.4% during 2016 to 2022, from 2015 market value of $3,420 million.
The geographical segmentation of the electrophysiology market includes North America, Europe, Asia-Pacific, and LAMEA. In 2015, North America accounted for the largest market share of 36.2% in the EP market and estimated to retain its dominant position throughout the forecast period. The growth in this region is mainly due to the factors such as product innovations, sophisticated healthcare infrastructure, U.S. – being the target area for the top players in the market owing to high prevalence rate of AF. Nevertheless, Asia Pacific region is expected to emerge as the area with maximum growth potential due to the rising number of cardiovascular diseases, presence of high unmet needs, and increased focus of key players towards emerging markets such as China and India, and increased healthcare spending for the development of improved healthcare infrastructure.
Inquiry before buying report @ http://www.marketintelreports.com/inquiry-before-buying.php?id=li%2016452
Segmentations & Key Players Involved in the Electrophysiology Market
The Electrophysiology Market can be broken down into various segmentations on the basis of -
Product: EP Ablation Catheters (Cryoablation EP Catheters, Radiofrequency Ablation Catheters, Microwave Ablation Systems, Laser Ablation Systems, Navigational Advanced Mapping Accessories), EP Laboratory Devices (EP X-Ray Systems, 3D Mapping Systems, EP Recording Systems, EP Remote Steering Systems, Others), EP Diagnostic Catheters (Convertible EP Diagnostic Catheters, Advanced EP Diagnostic Catheters, Ultrasound EP Diagnostic Catheters), Access Devices and Others.
Indication: Atrial Fibrillation (AF), Atrial Flutter, Wolff-Parkinson-White Syndrome (WPW), Atrioventricular Nodal Reentry Tachycardia (AVNRT) and Others.
Geographical Location: North America, Europe, Asia-Pacific and LAMEA.
Some of the key players involved in the Electrophysiology Market are as follows:
- Abbott Laboratories
- Johnson & Johnson
- Microport Scientific Corporation
- Boston Scientific Corporation
- St. Jude Medical, Inc.
- Medtronic plc
- Biotronik SE & Co. KG
- Koninklijke Philips N.V.
- General Electric Co.
- Siemens AG
Why buy this report?
- Get a detailed picture of the Electrophysiology Market.
- Pinpoint growth sectors and identify factors driving change.
- Understand the competitive environment, the market’s major players and leading brands.
- A five-year forecast method is used in order to assess how the market is predicted to develop.
Purchase a copy of research report @ http://www.marketintelreports.com/purchase.php?id=li%2016452
About Us:
MarketIntelReports (MIR) aims to empower our clients to successfully manage and outperform in their business decisions. We do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.
MarketIntelReports currently has more than 150,000 plus titles and 100+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.
Media Contact
Company Name: Market Intel Reports
Contact Person: Mayur S
Email: [email protected]
Phone: 1-302-261-5343
Address: 2712 Centerville Road, Suite 400
City: Wilmington
State: Delaware
Country: United States


Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 



